Janier M F, Vanoverschelde J L, Bergmann S R
Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri 63110.
Am J Physiol. 1994 Oct;267(4 Pt 2):H1353-60. doi: 10.1152/ajpheart.1994.267.4.H1353.
Preconditioning decreases ischemic injury, preserves tissue ATP content, and enhances the salutary effects of reperfusion. To evaluate whether preserved ATP is related to reduced utilization or increased production, 28 paced isolated rabbit hearts, perfused at constant flow, were subjected to 3 min of transient no-flow ischemia followed 12 min later by 1 h of low-flow ischemia and 45 min of reperfusion. Results were compared with those from 34 control hearts subjected to ischemia and reperfusion without preconditioning. Preconditioning delayed the onset of ischemic contracture and decreased its amplitude. At the end of ischemia, tissue ATP content was higher in hearts subjected to preconditioning (9.8 +/- 3.3 vs. 4.5 +/- 1.1 mumol/g dry wt; P < 0.01), accounted for by increased anaerobic ATP production using exogenous glucose. Preconditioning decreased ischemic damage (creatine kinase release 373 +/- 199 vs. 587 +/- 291 U/g dry wt; P < 0.05) and resulted in better functional recovery with reperfusion (74 +/- 11% of baseline developed pressure vs. 60 +/- 23%; P < 0.05). Thus preconditioning appears to protect ischemic myocardium by enhancing anaerobic glycolytic production of ATP using exogenous glucose.
预处理可减轻缺血性损伤,维持组织ATP含量,并增强再灌注的有益作用。为评估ATP含量的维持是与利用减少还是生成增加有关,对28个以恒定流量灌注的家兔起搏离体心脏进行3分钟短暂无血流缺血处理,12分钟后再进行1小时低血流缺血处理及45分钟再灌注处理。将结果与34个未进行预处理而直接进行缺血及再灌注处理的对照心脏的结果进行比较。预处理延迟了缺血性挛缩的发生并降低了其幅度。在缺血结束时,预处理组心脏的组织ATP含量更高(9.8±3.3对4.5±1.1μmol/g干重;P<0.01),这是由于利用外源性葡萄糖进行无氧ATP生成增加所致。预处理减轻了缺血损伤(肌酸激酶释放量为373±199对587±291U/g干重;P<0.05),并使再灌注时功能恢复更好(达基线舒张压力的74±11%对60±23%;P<0.05)。因此,预处理似乎是通过增强利用外源性葡萄糖进行无氧糖酵解生成ATP来保护缺血心肌。